TDC
CDNA icon

Thompson Davis & Co’s CareDx CDNA Stock Holding History

Thompson Davis & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,900
Closed -$330K – 156
2025
Q2 		$330K Sell
16,900
-5,100
-23% -$90.6K 0.23% 74
2025
Q1 		$391K Buy
22,000
+5,950
+37% +$128K 0.31% 62
2024
Q4 		$344K Buy
16,050
+950
+6% +$23.1K 0.22% 71
2024
Q3 		$471K Sell
15,100
-2,725
-15% -$67.8K 0.35% 50
2024
Q2 		$277K Buy
+17,825
New +$215K 0.24% 76
2018
Q3 		$433K Sell
15,000
-29,193
-66% -$546K 0.94% 19
2018
Q2 		$541K Sell
44,193
-29,023
-40% -$333K 1.29% 11
2018
Q1 		$584K Sell
73,216
-135,709
-65% -$836K 1.54% 10
2017
Q4 		$1.53M Buy
208,925
+5,233
+3% +$32.6K 3.63% 1
2017
Q3 		$754K Buy
203,692
+197,692
+3,295% +$415K 1.33% 9
2017
Q2 		$7K Buy
6,000
+1,500
+33% +$1.59K 0.01% 742
2017
Q1 		$6K Buy
4,500
+2,500
+125% +$5.57K 0.01% 839
2016
Q4 		$5K Hold
2,000
– – 0.01% 847
2016
Q3 		$7K Hold
2,000
– – 0.01% 739
2016
Q2 		$9K Hold
2,000
– – 0.01% 656
2016
Q1 		$10K Hold
2,000
– – 0.01% 646
2015
Q4 		$13K Hold
2,000
– – 0.02% 586
2015
Q3 		$8K Hold
2,000
– – 0.01% 710
2015
Q2 		$13K Sell
2,000
-1,500
-43% -$8.15K 0.02% 657
2015
Q1 		$19K Buy
+3,500
New +$23.1K 0.02% 534

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Thompson Davis & Co's CDNA Position: Q3 2025 in Review

Thompson Davis & Co sold out of CareDx (CDNA) in Q3 2025, closing a stake of 16,900 shares — an estimated $330K sold.

Thompson Davis & Co first reported a position in CDNA in Q1 2015 and held it in 20 quarters. The position peaked at $1.53M in Q4 2017. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Thompson Davis & Co reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Thompson Davis & Co sold 16,900 CareDx shares in Q3 2025, an estimated $330K.
  • Thompson Davis & Co first reported a position in CareDx in Q1 2015 and held it in 20 quarters.
  • Thompson Davis & Co's CareDx position peaked at $1.53M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Thompson Davis & Co's 13F filing for Q3 2025, filed 5 Nov 2025.